News
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
License out/inDiagnostic Reagents
Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate  NBI-1117568
Clinical ResultLicense out/in
First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company
ImmunotherapyClinical Study
European Commission Decision to approve the pediatric use of antifungal Cresemba® (isavuconazole) and extension of market exclusivity triggers CHF 10 million milestone payment to Basilea
Drug ApprovalLicense out/inOrphan DrugClinical Result
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
VaccineEmergency Use AuthorizationmRNA
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
ImmunotherapyASCO
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
Acquisition
Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.
Drug ApprovalLicense out/in
09 Aug 2024
CollaborateGene Therapy
EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
AcquisitionLicense out/in